Erythromelalgia successfully treated with low-dose gabapentin in a pediatric patient-Reference-Cited by-同舟云学术

Erythromelalgia successfully treated with low-dose gabapentin in a pediatric patient

Published:2022-01 Issue: Volume:10 Page:2050313X2211367
ISSN:2050-313X
Container-title:SAGE Open Medical Case Reports
language:en
Short-container-title:SAGE Open Medical Case Reports

Author:

Phong Celine H¹^ORCID,Birmingham Suzanne W²,Rojek Nathan W²

Affiliation:

1. School of Medicine, University of California, Irvine, CA, USA

2. Department of Dermatology, University of California, Irvine, CA, USA

Abstract

Primary erythromelalgia, while uncommon, may significantly decrease the quality of life of those affected. While many patients with erythromelalgia require systemic therapy, there is no standard of care for this condition. Herein, we report a 7-year-old girl who experienced resolution of erythromelalgia symptoms with no adverse effects after treatment with low-dose gabapentin. We also discuss the safety and efficacy of low-dose gabapentin in children for treatment of pain.

Publisher

SAGE Publications

Subject

General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/2050313X221136768

Reference10 articles.

1. Bogner MC. Burning for hope, 2016, https://www.huffpost.com/entry/burning-for-hope_b_9618652

2. Pediatric erythromelalgia: A?retrospective review of 32 cases evaluated at Mayo Clinic over a 37-year period

3. How a Simple Ankle Sprain Turned Into Neuropathic Pain: Complex Reflex Sympathetic Dystrophy Versus Erythromelalgia

4. Erythromelalgia Pain Managed with Gabapentin

5. Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in theSCN9Agene, encoding a voltage-gated sodium channel